Joel Owen - Concepedia

Author

Joel Owen

Cognizant (United States)ORCID

Also Known As

J S Owen, J. Owen, J. S. Owen, JOEL OWEN, Joel Owen, Joel S Owen, Joel S. Owen, Owen,Joel

117

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Cognizant (United States)Union University New York University Karolinska Institutet Karolinska University Hospital

About

Joel Owen is an author at Cognizant (United States) specializing in business, finance, and economics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Business	11	12	659
2	Management	5	5	487
3	Engineering	2	2	32
4	Health Sciences	2	2	106
5	Law	2	2	31

Joel Owen

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
On the Class of Elliptical Distributions and their Applications to the Theory of Portfolio Choice Joel Owen, Ramon Rabinovitch The Journal of Finance Empirical FinanceAsset AllocationElliptical DistributionsPortfolio ChoiceFinancial Mathematics	1983	364
Mycophenolic Acid 12-h Trough Level Monitoring in Renal Transplantation: Association with Acute Rejection and Toxicity Richard Borrows, Gary Chusney, Marina Loucaidou, American Journal of Transplantation TransplantationKidney TransplantMedicineKidney TransplantationTransplantation Medicine	2005	138
Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy Neill Duncan, Ajay Dhaygude, Joel Owen, Nephrology Dialysis Transplantation	2004	90
Pharmacogenetic-Based Efavirenz Dose Modification: Suggestions for an African Population and the Different CYP2B6 Genotypes Jackson Mukonzo, Joel Owen, Jasper Ogwal‐Okeng, PLoS ONE	2014	72
Pharmacokinetics, safety, and tolerability of ascending single intravenous doses of oritavancin administered to healthy human subjects Sujata M. Bhavnani, Joel Owen, Jeffery S. Loutit, Diagnostic Microbiology and Infectious Disease Drug SafetyPharmacological StudyPharmacologyPharmacotherapySingle Intravenous Doses	2004	67
Bendamustine pharmacokinetic profile and exposure–response relationships in patients with indolent non-Hodgkin’s lymphoma Joel Owen, Murad Melhem, Julie Passarell, Cancer Chemotherapy and Pharmacology Lymphoid NeoplasiaTherapeutic Drug MonitoringOncologyBendamustine Pharmacokinetic ProfileExposure–response Relationships	2010	67
Population Pharmacokinetics of Tigecycline in Patients with Complicated Intra-Abdominal or Skin and Skin Structure Infections Scott A. Van Wart, Joel Owen, Elizabeth Ludwig, Antimicrobial Agents and Chemotherapy Tigecycline ClearanceAntimicrobial ChemotherapyPopulation PharmacokineticsDermatologyDrug Allergy	2006	67
On the Class of Elliptical Distributions and their Applications to the Theory of Portfolio Choice Joel Owen, Ramon Rabinovitch The Journal of Finance Empirical FinanceAsset AllocationElliptical DistributionsPortfolio ChoiceFinancial Mathematics	1983	66
Pharmacokinetic-Pharmacodynamic Relationships Describing the Efficacy of Oritavancin in Patients with <i>Staphylococcus aureus</i> Bacteremia Sujata M. Bhavnani, Julie Passarell, Joel Owen, Antimicrobial Agents and Chemotherapy	2006	57
Privatization: Choosing the Optimal Time Path Barbara G. Katz, Joel Owen Journal of Comparative Economics EconomicsOptimal Time PathBusinessPrivatizationResource Allocation	1993	48

Page 1